UK Single-cell Omics Market Size & Outlook, 2023-2030
The single-cell omics market in UK is expected to reach a projected revenue of US$ 337.9 million by 2030. A compound annual growth rate of 17.8% is expected of UK single-cell omics market from 2024 to 2030.
Revenue, 2023 (US$M)
$107.2
Forecast, 2030 (US$M)
$337.9
CAGR, 2024 - 2030
17.8%
Report Coverage
UK
UK single-cell omics market, 2018-2030 (US$M)
Related Markets
UK single-cell omics market highlights
- The UK single-cell omics market generated a revenue of USD 107.2 million in 2023 and is expected to reach USD 337.9 million by 2030.
- The UK market is expected to grow at a CAGR of 17.8% from 2024 to 2030.
- In terms of segment, single-cell genomics was the largest revenue generating product in 2023.
- Single-Cell Metabolomics is the most lucrative product segment registering the fastest growth during the forecast period.
Single-cell omics market data book summary
| Market revenue in 2023 | USD 107.2 million |
| Market revenue in 2030 | USD 337.9 million |
| Growth rate | 17.8% (CAGR from 2023 to 2030) |
| Largest segment | Single-cell genomics |
| Fastest growing segment | Single-Cell Metabolomics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics |
| Key market players worldwide | Danaher Corp, 10x Genomics Inc Ordinary Shares - Class A, BD, PerkinElmer, ANGLE PLC, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, Cytena, Cellenion, Mission Bio |
Other key industry trends
- In terms of revenue, UK accounted for 6.6% of the global single-cell omics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany single-cell omics market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 264.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Single-cell Omics Market Scope
Single-cell omics market segmentation & scope
Others
Single-cell Omics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK single-cell omics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single-cell omics market will help companies and investors design strategic landscapes.
Single-cell genomics was the largest segment with a revenue share of 45.9% in 2023. Horizon Databook has segmented the UK single-cell omics market based on single-cell genomics, single-cell transcriptomics, single-cell proteomics, single-cell metabolomics covering the revenue growth of each sub-segment from 2018 to 2030.
- UK Single-cell Omics Product Outlook (Revenue, USD Million, 2018-2030)
- Single-Cell Genomics
- Single-Cell Transcriptomics
- Single-Cell Proteomics
- Single-Cell Metabolomics
- UK Single-cell Omics Application Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Cell Biology
- Neurology
- Immunology
- UK Single-cell Omics End-user Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Organizations
- Hospital & Diagnostic Laboratories
- Others
Reasons to subscribe to UK single-cell omics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK single-cell omics market databook
-
Our clientele includes a mix of single-cell omics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK single-cell omics market , including forecasts for subscribers. This country databook contains high-level insights into UK single-cell omics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK single-cell omics market size, by product, 2018-2030 (US$M)
UK Single-cell Omics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
